Regeneron Pharmaceuticals Inc. (REGN): Price and Financial Metrics

REGN POWR Grades

• Quality is the dimension where REGN ranks best; there it ranks ahead of 86.92% of US stocks.
• The strongest trend for REGN is in Quality, which has been heading down over the past 177 days.
• REGN ranks lowest in Growth; there it ranks in the 1st percentile.

REGN Stock Summary

• REGN has a higher market value than 97.36% of US stocks; more precisely, its current market capitalization is $81,807,133,572.
• REGENERON PHARMACEUTICALS INC's stock had its IPO on April 2, 1991, making it an older stock than 85.39% of US equities in our set.
• Of note is the ratio of REGENERON PHARMACEUTICALS INC's sales and general administrative expense to its total operating expenses; just 17.8% of US stocks have a lower such ratio.
• Stocks with similar financial metrics, market capitalization, and price volatility to REGENERON PHARMACEUTICALS INC are LRCX, AMAT, VRTX, CDNS, and SNPS.
• REGN's SEC filings can be seen here. And to visit REGENERON PHARMACEUTICALS INC's official web site, go to www.regeneron.com.

REGN Valuation Summary

• REGN's EV/EBIT ratio is 13; this is 28.08% higher than that of the median Healthcare stock.
• REGN's EV/EBIT ratio has moved up 21.9 over the prior 243 months.

Below are key valuation metrics over time for REGN.

REGN Growth Metrics

The 5 year revenue growth rate now stands at 60.28%.
• Its 3 year price growth rate is now at 104.98%.
• The 3 year revenue growth rate now stands at 138.86%.

Over the past 33 months, REGN's revenue has gone up $5,846,800,000.

The table below shows REGN's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	13,710.2	5,667.5	5,370.3
2022-06-30	14,226.8	8,452.2	5,686.8
2022-03-31	16,508.1	8,514.5	7,933.6
2021-12-31	16,071.7	7,081.3	8,075.3
2021-09-30	13,542.9	5,939.8	6,995.5
2021-06-30	12,384.1	2,271.9	6,205.4

REGN's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• REGN has a Quality Grade of B, ranking ahead of 86.94% of graded US stocks.
• REGN's asset turnover comes in at 0.683 -- ranking 43rd of 681 Pharmaceutical Products stocks.
• JAZZ, AGLE, and VERU are the stocks whose asset turnover ratios are most correlated with REGN.

The table below shows REGN's key quality metrics over time.